Skip to content. | Skip to navigation

Garvan Institute

 
Sections
 

Garvan Breakthroughs

One of our most exciting research projects involves seeing how we can harness the brain’s own adult stem cells, which normally function to repair injury to the brain and make new nerve cell connections, to help treat Parkinson’s disease, as well as other neurodegenerative conditions.


Donate Now

Your support makes it possible for the Garvan scientists to continue their great work. You can help by making a donation or a bequest, holding a community fundraiser or volunteering your time for Garvan.

Donate

Quick Facts

The average age of diagnosis is 65 years, but one in seven cases are diagnosed under 45 years of age

Parkinson’s disease patients have lost at least 80% of their dopamine-producing cells by the time symptoms appear

 

Parkinson's Disease Related News

 

Findings that should speed the development of drugs for Parkinson’s Disease

MEDIA RELEASE: 18 Nov 2009
Neuroscientists at Garvan have significantly advanced our understanding of dopamine release from nerve cells, findings that should speed the development of more effective drugs for treating Parkinson’s Disease. 


Findings that should speed the development of drugs for Parkinson’s Disease
 
 

Harnessing the brain's own ability for repair

MEDIA RELEASE: 02 Jun 2009
New findings uncovered by Garvan scientists throw light on how the brain heals itself and may change the way we think about treating chronic neurodegenerative diseases like Parkinson's and Alzheimer's.
Harnessing the brain's own ability for repair
 
 

How yeast is helping us to understand Parkinson's disease
MEDIA RELEASE: 27 Feb 2009
Teams of scientists from Australia and the United States have used yeast and mammalian cells to discover a connection between genetic and environmental causes of Parkinson’s disease. The findings were published online this month in Nature Genetics.
How yeast is helping us to understand Parkinson's disease
 
 
Personal tools